Treatment with bimekizumab vs secukinumab led to faster and more durable improvements in PROs in patients with moderate to severe plaque PsO.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results